FDA reverses decades of guidance on hormone therapy for menopause

FDA reverses decades of guidance on hormone therapy for menopause

  • Af
  • Episode
      1775
  • Published
      11. nov. 2025
  • Forlag
0 Anmeldelser
0
Episode
1775 of 1839
Længde
12M
Sprog
Engelsk
Format
Kategori
Fakta

The FDA is removing the black box warning on estrogen therapy after two decades. Should it?

Women who want to use estrogen to treat menopause symptoms often face a difficult choice.

That’s because those hormone treatments contain a “black-box warning.”

The Food and Drug Administration uses black box warnings to indicate a medication has potentially life threatening side effects.

In the case of estrogen for menopause symptoms, an increased risk of endometrial cancer, cardiovascular disorders, dementia and breast cancer.

Well those warnings are going away.

For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org. Email us at considerthis@npr.org.

This episode was produced by Mia Venkat and Erika Ryan. It was edited by Courtney Dorning and Scott Hensley.

Our executive producer is Sami Yenigun.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for FDA reverses decades of guidance on hormone therapy for menopause

Other podcasts you might like ...